About this Medicine article
P-159 HERIZON: Phase 2 part of the IMU-131 HER2/neu vaccine plus chemotherapy study randomized in patients with HER2/NEU overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction by Maglakelidze, M. (author);Ryspayenva, D. (author);Bulat, I. (author);Andric, Z. (author);Nikolic, I. (author);Chawla, T. (author);Choudhary, V. (author);Venkata, G. (author);Radosavljevic, D. (author);Petrovic, Z. (author);Wiedermann, U. (author);Chong, L. (author);Laeufle, R. (author);Ede, N. (author);Nixon, B. (author);Good, A. (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Maglakelidze, M. (author);Ryspayenva, D. (author);Bulat, I. (author);Andric, Z. (author);Nikolic, I. (author);Chawla, T. (author);Choudhary, V. (author);Venkata, G. (author);Radosavljevic, D. (author);Petrovic, Z. (author);Wiedermann, U. (author);Chong, L. (author);Laeufle, R. (author);Ede, N. (author);Nixon, B. (author);Good, A. (author)
- Publisher
- Elsevier BV
- Published
- 2021
- Field
- Medicine (Health Sciences)